Medical News

RSS

Phage therapy can combat Pseudomonas infections in CF patients

Scientists in Cork have identified a novel therapy for the bacteria which cause infections in cystic fibrosis patients.

2 Apr 2012

Leicester Kidney Exercise Team shortlisted for BMJ award

A team of researchers from the University of Leicester, Leicester's Hospitals and the University of Loughborough are in the running for a prestigious medical award.

2 Apr 2012

Medworxx announces addition of York Central Hospital

Medworxx Inc., a leader in clinical patient flow, compliance and education solutions, today announces the addition of York Central Hospital in Richmond Hill, ON, to the Medworxx Patient Flow community, licensing 370 beds at the hospital. York Central is located in one of Canada's fastest growing communities, and now joins the fold of Medworxx Patient Flow clients representing 38% of acute-care beds in Ontario, and 30% nationwide.

2 Apr 2012

ACAAI/AAAAI publish position statement in support of ATS guideline on Aerocrine's FeNO test

Aerocrine AB announces that a nine-member council representing both prestigious asthma societies, the American Academy and the American College of Allergy, Asthma and Immunology (ACAAI and AAAAI), have published a position statement in support of the clinical practice guideline on Aerocrine's FeNO test as published by the ATS.

2 Apr 2012

TGen to present TNBC study at AACR 2012 annual meeting

Because cases of Triple-Negative Breast Cancer (TNBC) are so genetically different, whole-genome sequencing is needed to detect the subtle molecular differences that might point to specific treatments for individual patients.

2 Apr 2012

Therakos introduces Lighting Up Lives campaign for patients with immune diseases

Therakos, Inc., a pioneer in the development of an innovative immune modulation therapy called extracorporeal photopheresis (ECP), today launched Lighting Up Lives, a 25-year anniversary campaign and year-long global initiative that honours the lives of patients with serious immune diseases impacted by ECP, as well as the healthcare professionals, caregivers and treatment centres that support them every step of the way.

2 Apr 2012

ViiV, Shionogi announce initial results from dolutegravir Phase III study on HIV-1

ViiV Healthcare and Shionogi & Co., Ltd. today announced that initial results have been received from the SPRING-2 (ING113086) Phase III study of the investigational integrase inhibitor dolutegravir in treatment-naive adults with HIV-1.

2 Apr 2012

Allowing the heart to rest can reverse structural changes in myocytes after heart failure

Structural changes in heart muscle cells after heart failure can be reversed by allowing the heart to rest, according to research at Imperial College London. Findings from a study in rats published today in the European Journal of Heart Failure show that the condition's effects on heart muscle cells are not permanent, as has generally been thought. The discovery could open the door to new treatment strategies.

2 Apr 2012

Scientists use DNA sequencing to identify 'driver' mutations in cancer

Scientists at Washington University School of Medicine in St. Louis are using powerful DNA sequencing technology not only to identify mutations at the root of a patient's tumor - considered key to personalizing cancer treatment - but to map the genetic evolution of disease and monitor response to treatment.

2 Apr 2012

Elekta receives clearance to CE mark Agility device

Elekta announced today it has received clearance to CE mark Agility, a revolutionary beam-shaping device integrated into the head of a linear accelerator (linac). Patients and clinics will benefit from the speed and reliability of this new MLC design.

From Elekta 2 Apr 2012

RT3D may boost effects of two standard chemotherapy drugs in head and neck cancer patients

A naturally-occurring harmless human virus may be able to boost the effects of two standard chemotherapy drugs in some cancer patients, according to early stage trial data published today in Clinical Cancer Research.

2 Apr 2012

Twins and mothers with poor nutrition more likely to develop obesity, type 2 diabetes

If you're expecting, this might make you feel a little better about reaching for that pint of ice cream: New research published online in the FASEB Journal suggests that twins, and babies of mothers who diet around the time of conception and in early pregnancy, may have an increased risk of obesity and type 2 diabetes throughout their lives.

2 Apr 2012

Studies use three genes to reprogram fibroblasts into myocytes

The latest research developments to reprogram scar tissue resulting from myocardial infarction (MI) into viable heart muscle cells, were presented at the Frontiers in CardioVascular Biology (FCVB) 2012 meeting, held 30 March to 1 April at the South Kensington Campus of Imperial College in London.

2 Apr 2012

RNA binding motif protein 20 regulates titin splicing

Cardiomyopathy comprises a deterioration of the heart muscle that affects the organ's ability to efficiently pump blood through the body. Previously researchers have tied forms of the disease to the alternative splicing of titin, a giant protein that determines the structure and biomechanical properties of the heart, but the molecular mechanism remained unknown.

2 Apr 2012

Genetic variations could be linked with meconium ileus in CF patients

University of North Carolina at Chapel Hill researchers working as part of the International Cystic Fibrosis Consortium have discovered several regions of the genome that may predispose cystic fibrosis (CF) patients to develop an intestinal blockage while still in the uterus.

2 Apr 2012

New guidelines offer guidance on how and when to switch between RA drug classes

A trend toward more aggressive treatment in patients just starting to develop rheumatoid arthritis is among the most important changes in treatment guidelines for the disease, according to updated American College of Rheumatology recommendations published today in the journal Arthritis Care & Research. The trend may proceed from emerging opinions that joint damage caused by RA is irreversible, and that early, intensive therapy better preserves physical function, quality of life and capacity to work.

2 Apr 2012

Survivin protein could be a useful tool in understanding pancreatic cancer

Pancreatic cancer kills more than 40,000 people every year, and among cancers it's particularly insidious. For 80 percent of patients, the disease is already so advanced at the time of diagnosis that treatment is unlikely to provide significantly life-extending benefits. For patients diagnosed with localized pancreatic cancer, the five-year survival rate remains barely above 20 percent, according to the National Cancer Institute.

2 Apr 2012

Novartis achieves primary endpoints in all three of QVA149 Phase III studies on COPD

Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.

2 Apr 2012

WCMC receives SU2C-PCF Prostate Dream Team Translational Cancer Research Grant

An international team of investigators from centers in the United States and the United Kingdom, including Weill Cornell Medical College, have been awarded a grant for $10 million over a three-year period to study the molecular underpinnings of metastatic prostate cancer while creating a comprehensive testing system to optimize personalized treatments.

2 Apr 2012

Bruker acquires SkyScan

Bruker Corporation today announced that it has acquired all of the shares of SkyScan N.V., a scientific instruments company located near Antwerp, Belgium. Financial details were not disclosed. For the remainder for 2012, the acquisition of SkyScan is expected to add approximately $13 million to Bruker's revenue and to be accretive to EPS by about $0.01.

2 Apr 2012

Medical News

Phage therapy can combat Pseudomonas infections in CF patients

Leicester Kidney Exercise Team shortlisted for BMJ award

Medworxx announces addition of York Central Hospital

ACAAI/AAAAI publish position statement in support of ATS guideline on Aerocrine's FeNO test

TGen to present TNBC study at AACR 2012 annual meeting

Therakos introduces Lighting Up Lives campaign for patients with immune diseases

ViiV, Shionogi announce initial results from dolutegravir Phase III study on HIV-1

Allowing the heart to rest can reverse structural changes in myocytes after heart failure

Scientists use DNA sequencing to identify 'driver' mutations in cancer

Elekta receives clearance to CE mark Agility device

RT3D may boost effects of two standard chemotherapy drugs in head and neck cancer patients

Twins and mothers with poor nutrition more likely to develop obesity, type 2 diabetes

Studies use three genes to reprogram fibroblasts into myocytes

RNA binding motif protein 20 regulates titin splicing

Genetic variations could be linked with meconium ileus in CF patients

New guidelines offer guidance on how and when to switch between RA drug classes

Survivin protein could be a useful tool in understanding pancreatic cancer

Novartis achieves primary endpoints in all three of QVA149 Phase III studies on COPD

WCMC receives SU2C-PCF Prostate Dream Team Translational Cancer Research Grant

Bruker acquires SkyScan

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News